Group subsidiaries like yours – which are typically in high-tax territories - pay the Cayman entity royalties for the IP they use to reduce their taxable profits.
The Cayman company pays for the R&D in exchange for the IP rights. This Cayman company makes a nice big profit but that’s fine because it pays hardly any tax.
None of this should affect innovation within the subsidiary. If it needs money for R&D, it can ask for it and if it wants to use the resulting IP, it simply asks for a license and pays royalties. It is all still inside the group.
And yet poised to innovate, you hesitate. Will you – as a business or individual – be rewarded for generating a return from the new products that result from the IP you generate?
You might reasonably ask yourself, if any formal IP is generated, is it worth exploiting it to the full, knowing that profits will disappear from your top line with limited contribution to your bottom line KPIs?
Wouldn’t it have been easier if you paid for your own R&D and exploited resulting IP locally? You wish you could just back your own judgement and be accountable for the return.
How much truth is there in this scenario?
Much has been written about the tax advantages of transferring ownership of multinational company assets – including IP (patents, trademarks, copyright etc.) to ‘special purpose vehicles’ in low-tax regimes to which other group companies pay royalties.
However, there has been little consideration given to the, unintended, consequences of such structures. The conventional wisdom is that these consequences are minor. After all, the subsidiaries are 100% group-owned and therefore part of one family.